Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
February 19, 2026
Technology
-
-
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA(TM) (bevacizumab gamma) in Switzerland
February 19, 2026
-
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
-
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
February 18, 2026
-
WidePoint Corporation Announces $1.3 Million Managed Services Win with Leading Beverage Bottler
February 18, 2026
-
Cubic Corporation Optimizes SAP Support with Rimini Street to Accelerate Modernization
February 18, 2026
-
Digerati Technologies Strengthens Balance Sheet with All $10 Million of Notes Converting to Equity
February 18, 2026
-
VivoPower’s Board of Directors Increases Aggregate Shareholding By 2.65 Million Shares
February 18, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
February 18, 2026
-
Gorilla Technology Acquires Shackleton Finance to Establish Regulated Capital Platform and Fund AI Infrastructure Growth
February 18, 2026
-
CEL-SCI Reports Fiscal First Quarter 2026 Results
February 18, 2026
-
Project Bedrock: Resilient Infrastructure for the Next Era of Compute
February 17, 2026
-
Following Pilot Results Ohio Hospital Network Expands OMNIQ AI To Additional Campuses
February 17, 2026
-
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
February 17, 2026
-
Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
February 17, 2026
-
AI, Integration Boost Field Service Effectiveness, ISG Says
February 17, 2026